Still miles from concept to commercialization. And Tangiers is involved? These guys are going to go a lot deeper in debt until they finally have a feasible prototype that can be scaled to production. Simply put, debt on debt on debt. Best time to get in would be when studies are complete, have FDA approval ducks lined up, and right before they start turning a profit. Anything else is hot air and would expect this to drop to lower levels and Reverse splits to pass on the debt to the shareholders... Think I'm going to save some bucks by not jumping the gun here, and set an alert for a few months/years from now to get in.
Best of luck - If I missed something let me know.
____________
Seaheck, I agree to your reply. And do think this would be good for day trades on some days, especially with the excitment Stem Cell/re-genitive RX market. I might even give it a couple of good flips, but don't intend on leaving my money sitting here while looking the other way.
Cheers
News 
Market Data 
Discover 
AI
